SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-005344
Filing Date
2017-05-10
Accepted
2017-05-10 16:05:31
Documents
62
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q trov-033117x10q.htm 10-Q 858944
2 EXHIBIT 31.1 trov-033117exhibit311.htm EX-31.1 13471
3 EXHIBIT 32.1 trov-033117exhibit321.htm EX-32.1 6153
  Complete submission text file 0001628280-17-005344.txt   4995653

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT trov-20170331.xml EX-101.INS 963289
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trov-20170331.xsd EX-101.SCH 34758
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trov-20170331_cal.xml EX-101.CAL 69345
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trov-20170331_def.xml EX-101.DEF 214017
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trov-20170331_lab.xml EX-101.LAB 569632
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trov-20170331_pre.xml EX-101.PRE 341478
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-217-5420
Trovagene, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 043721895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35558 | Film No.: 17830214
SIC: 2836 Biological Products, (No Diagnostic Substances)